Medical Current Affairs - 2019
Category Wise PDF Compilations available at This Link
India’s largest Cancer Institute, National Cancer Institute (NCI), has opened on 18th December 2018 in Jhajjar, Haryana for public services. The National Cancer Institute will be formally inaugurated in January 2019.
The National Cancer Institute has been established under a project of Delhi’s All India Institute of Medical Sciences (AIIMS). Dr G.K. Rath, head of Institute Rotary Cancer hospital at All India Institute of Medical Sciences in Delhi, will head the NCI.
About the National Cancer Institute:
- The NCI is built at a cost of Rs 2,035 crore. Presently, NCI has a total of 710 beds out of which 200 beds have been dedicated for the treatment of cancer patients based on research protocols.
- The National Cancer Institute (NCI) will act as the nodal institution for all cancer-related activities in India.
- It will be linked to regional cancer centres and other cancer institutes of India.
- The NCI will be the premier institute for cancer treatment and research. It is tasked to conduct basic and applied research in areas like molecular biology, genomics, proteomics, cancer epidemiology, radiation biology, cancer vaccines and more.
- It will work towards evolving new cancer control strategies, which include new models of prevention, early diagnosis and therapy, for the developing nations.
- Development of human resource in various branches of cancer management is another area where NCI will work.
- NCI will also have the facilities for training and capacity building in cancer treatment.
- The NCI will have equipment with advanced and latest technology to learn more about cancer.
- NCI will assist other regional cancer centres in research activities.
The National Cancer Institute (NCI) will help to take off some patient load from AIIMS which presently receives about 1000 patients every day. Although the doctors have started OPDs in the NCI, the full functioning of all the departments of the National Cancer Institute will commence in January 2019.
India was declared free from infective Trachoma, a contagious bacterial infection of the eye. The infection causes inflamed granulation on the inner surface of the lids.
It was announced by Union Health Minister J P Nadda after releasing National Trachoma Survey Report (2014-17) in New Delhi. With this, India met goal of trachoma elimination as specified by World Health Organisation (WHO) under its GET2020 (Global Elimination of Trachoma by the year 2020) program.
Trachoma is a chronic infective disease of eye and is leading cause of infective blindness globally. It is outcome of poor environmental and personal hygiene and inadequate access to water and sanitation. It affects conjunctiva under the eyelids.
Repeated Trachoma infection causes scarring leading to in-turning of the eyelashes and eyelids which further causes damage to cornea and blindness. It is main cause of corneal blindness in India, affecting young children. It was found affecting the population North Indian states like Gujarat, Punjab, Haryana, Rajasthan, Uttar Pradesh.
National Trachoma Survey Report (2014-17)
The Survey results indicate that active Trachoma is no longer a public health problem in India. It was possible due to decades of inter-sectoral interventions and efforts that included provision of antibiotic eye drops, personal hygiene, improved environmental sanitation, availability of safe water, availability of surgical facilities for chronic trachoma.
Trachoma has been eliminated among children below 10 years in all survey districts with overall prevalence of only 0.7%, much below elimination criteria of infective trachoma as defined by WHO. As per WHO targets, Trachoma is considered eliminated if prevalence of active infection among children below 10 years is less than 5%.